Xinxue Liu
Churchill Hospital(GB)Oxford Research Group(GB)Oxford Health NHS Foundation Trust(GB)National Institute for Health Research(GB)University of Oxford(GB)Oxford BioMedica (United Kingdom)(GB)Science Oxford(GB)Oxford University Hospitals NHS Trust(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Esophageal Cancer Research and Treatment, Salmonella and Campylobacter epidemiology, Viral gastroenteritis research and epidemiology, Vaccine Coverage and Hesitancy
Most-Cited Works
- → Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial(2021)540 cited
- → Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study(2022)466 cited
- → Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum(2021)363 cited
- → A Randomized Trial of Early Endovenous Ablation in Venous Ulceration(2018)360 cited
- → Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses(2020)336 cited
- → Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data